Safety test of transcutaneous electrical sensory stimulation treatment for head and neck cancer patients treated with chemo-radiotherapy

Hamamoto Takao0 个研究点目标入组 10 人开始时间: 2022年4月13日最近更新: 2024年5月27日

适应症

试验速览

暂无简介。

•1. Patients undergoing chemoradiation therapy for head and neck cancer at Hiroshima University Hospital
•2. Patients who receive 70 Gy of radiation to the primary / laryngo-pharyngeal area
•3. Patients over 20 years old at the time of obtaining consent
•4. Patients who can obtain written consent from the individual regarding participation in this study

•1. Patients with a history of radiation therapy in the head and neck area
•2. Patients with tracheostomy
•3. Patients who irradiate mainly the part other than the laryngo-pharyngeal area
•4. Patients with pacemakers and implantable cardioverter-defibrillators
•5. Patients who are expected to have difficulty wearing IFCD on the neck
•6. Patients with many inconveniences in daily life (Performance Status 2 or higher)
•7. Patients who are pregnant, may become pregnant, or breastfeeding
•8. In addition, patients who are judged to be inappropriate by the principal investigator or the research coordinator

发起方

Hamamoto Takao